|1.||Savino, Francesco: 2 articles (01/2014 - 04/2002)|
|2.||Savino, F: 1 article (01/2015)|
|3.||Poggi, E: 1 article (01/2015)|
|4.||Cartosio, M E: 1 article (01/2015)|
|5.||Ceratto, S: 1 article (01/2015)|
|6.||Giannattasio, A: 1 article (01/2015)|
|7.||Cordero di Montezemolo, L: 1 article (01/2015)|
|8.||Ceratto, Simone: 1 article (01/2014)|
|9.||Cordero di Montezemolo, Luca: 1 article (01/2014)|
|10.||De Marco, Angela: 1 article (01/2014)|
|1.||Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
03/01/1990 - "The aim of this study was to evaluate the efficacy of cimetropium bromide, a new antimuscarinic compound, in relieving symptoms of patients with irritable bowel syndrome over a three month period. "
06/01/1989 - "The aim of this study was to evaluate the effects of oral cimetropium bromide on total gut transit time in patients with irritable bowel syndrome. "
03/01/1990 - "Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial."
06/01/1989 - "Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome."
11/01/1988 - "Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome."
03/01/1990 - "Pain score decreased by 40, 66, 85% in the cimetropium group, at the end of the first, second and third months respectively, compared with 26, 32 and 52% reductions among controls (p = 0.0005). "
11/01/1988 - "At the end of therapy, pain scores had decreased an average of 16% in the placebo group and 87% in the cimetropium group (p less than 0.01). "
01/01/2004 - "Taking into consideration the published trials carried out with validated methodology in irritable bowel syndrome, cimetropium and otilonium are the best demonstrated drugs for the improvement in global assessment, pain and abdominal distension."
03/01/1990 - "The results of this study showed that cimetropium bromide is effective in relieving pain in patients with irritable bowel syndrome."
07/01/1997 - "A double-blind study was conducted to evaluate the efficacy, safety and usefulness of cimetropium bromide (DA3177) in the patients with pain caused by upper urinary calculus at a daily dose of 75 mg t.i.d. "
|3.||octylonium (otilonium bromide)